HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USANA Active Nutrition Launch Emphasizes ‘Healthy Body’ For Immune System Support

Executive Summary

USANA Health Sciences’ Active Nutrition range, one of its biggest launches, places the focus of health and wellbeing on the gut microbiome for overall healthy body, rather than centering on weight loss.

You may also be interested in...



Supply Chain Disrupts USANA’s Launches

USANA reports some Active Nutrition supplement line extensions s could be delayed to early 2022 due to pandemic-related disruptions, but it reaffirms its full-year sales and diluted EPS projections.

US Wellness Market Q2 Results: USANA and Mannatech Climb, MusclePharm Slips On Costs

USANA expanding Active Nutrition line outside North America and extending it with bars, other products to attract additional customers as it transitions to a more holistic focus; MusclePharm ready for energy lines to drive sales; and Mannatech sales up with associates, customers up.

Spanish Firm’s Immunity-Boosting Probiotic Strains Approved For Use In Brazil

More than 446,000 people in Brazil have died from COVID-19, the second-highest total in the world after the US. Bioresearch Life’s probiotic strains shown to boost the immune system, a health benefit in demand as consumers try to remain coronavirus-free.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel